TRANSIENT EARLY POST-INOCULATION ANTIRETROVIRAL TREATMENT FACILITATES DEVELOPMENT OF SIV-SPECIFIC CELLULAR IMMUNE RESPONSES, SUSTAINED MODULATION OF VIRAL REPLICATION AND REVERSAL OF CD4+ T CELL DEPLETION FROM GALT IN SIV-INFECTED RHESUS MACAQUES.